Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
2003 2
2005 2
2006 2
2007 1
2008 1
2009 1
2010 3
2011 5
2012 1
2013 3
2020 1
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
[Diagnosis, prophylaxis and treatment of central nervous system involvement by non-Hodgkin lymphoma in HIV-infected patients].
Miralles P, Berenguer J, Ribera JM; grupo de estudio de la afección del sistema nervioso central en linfomas asociados a la infección por el virus de la inmunodeficiencia. Miralles P, et al. Med Clin (Barc). 2010 Sep 18;135(9):417-22. doi: 10.1016/j.medcli.2009.04.047. Epub 2009 Jul 22. Med Clin (Barc). 2010. PMID: 19628233 Review. Spanish.
Long-term follow-up of a prospective phase 2 clinical trial of extended treatment with rituximab in patients with B cell post-transplant lymphoproliferative disease and validation in real world patients.
González-Barca E, Capote FJ, Gómez-Codina J, Panizo C, Salar A, Sancho JM, López A, Briones J, Muñoz A, Encuentra M, Mercadal S, Domingo-Domenech E, de Sevilla AF; GELTAMO (Spanish Lymphoma Group) and GOTEL (Group of Oncology for Therapy and Study of Lymphomas). González-Barca E, et al. Among authors: de sevilla af. Ann Hematol. 2021 Apr;100(4):1023-1029. doi: 10.1007/s00277-020-04056-9. Epub 2020 May 4. Ann Hematol. 2021. PMID: 32367180 Clinical Trial.
Type 2 diabetes mellitus, its treatment and risk for lymphoma.
Fortuny J, Benavente Y, Bosch R, García-Villanueva M, de Sevilla AF, de Sanjosé S. Fortuny J, et al. Among authors: de sevilla af. Eur J Cancer. 2005 Aug;41(12):1782-7. doi: 10.1016/j.ejca.2005.04.032. Eur J Cancer. 2005. PMID: 16039111
Isoform-selective phosphoinositide 3-kinase inhibitors induce apoptosis in chronic lymphocytic leukaemia cells.
de Frias M, Iglesias-Serret D, Cosialls AM, González-Gironès DM, Pérez-Perarnau A, Rubio-Patiño C, Rückle T, Camps M, de Sevilla AF, de la Banda E, Pons G, Gil J. de Frias M, et al. Among authors: de sevilla af. Br J Haematol. 2010 Jul;150(1):108-11. doi: 10.1111/j.1365-2141.2010.08151.x. Epub 2010 Mar 11. Br J Haematol. 2010. PMID: 20230409 Free article. No abstract available.
Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma.
Sánchez-Aguilera A, Montalbán C, de la Cueva P, Sánchez-Verde L, Morente MM, García-Cosío M, García-Laraña J, Bellas C, Provencio M, Romagosa V, de Sevilla AF, Menárguez J, Sabín P, Mestre MJ, Méndez M, Fresno MF, Nicolás C, Piris MA, García JF; Spanish Hodgkin Lymphoma Study Group. Sánchez-Aguilera A, et al. Among authors: de sevilla af. Blood. 2006 Jul 15;108(2):662-8. doi: 10.1182/blood-2005-12-5125. Epub 2006 Mar 21. Blood. 2006. PMID: 16551964 Free article.
Frontline treatment of follicular lymphoma with fludarabine, cyclophosphamide, and rituximab followed by rituximab maintenance: toxicities overcome its high antilymphoma effect. Results from a Spanish Cooperative Trial (LNHF-03).
Tomás JF, Montalbán C, De Sevilla AF, Martínez-López J, Díaz N, Canales M, Martínez R, Sánchez-Godoy P, Caballero MD, Peñalver J, Prieto E, Salar A, Burgaleta C, Queizán JA, Bajo R, De Oña R, De La Serna J. Tomás JF, et al. Among authors: de sevilla af. Leuk Lymphoma. 2011 Mar;52(3):409-16. doi: 10.3109/10428194.2010.543717. Epub 2011 Jan 28. Leuk Lymphoma. 2011. PMID: 21275633 Clinical Trial.
20 results